145 related articles for article (PubMed ID: 27055781)
1. [Drug-induced Pulmonary Hypertension - a Current Review].
Günther S; Behr J; Knoop H
Pneumologie; 2016 May; 70(5):320-7. PubMed ID: 27055781
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced pulmonary arterial hypertension: a review.
Garg L; Akbar G; Agrawal S; Agarwal M; Khaddour L; Handa R; Garg A; Shah M; Patel B; Dalal BD
Heart Fail Rev; 2017 May; 22(3):289-297. PubMed ID: 28417295
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced pulmonary hypertension: must history repeat itself?
Voelkel NF
Pulm Pharmacol; 1996 Apr; 9(2):67-8. PubMed ID: 8880947
[No Abstract] [Full Text] [Related]
4. Drugs induced pulmonary arterial hypertension.
Seferian A; Chaumais MC; Savale L; Günther S; Tubert-Bitter P; Humbert M; Montani D
Presse Med; 2013 Sep; 42(9 Pt 2):e303-10. PubMed ID: 23972547
[TBL] [Abstract][Full Text] [Related]
5. Drug-associated pulmonary arterial hypertension.
McGee M; Whitehead N; Martin J; Collins N
Clin Toxicol (Phila); 2018 Sep; 56(9):801-809. PubMed ID: 29508628
[TBL] [Abstract][Full Text] [Related]
6. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
Wolf I; Mouallem M; Farfel Z
Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
[No Abstract] [Full Text] [Related]
7. Selections from current literature: pharmacological treatment of obesity.
Connolly J; Verni C; Trilling J; Kelso E; Shiesha S
Fam Pract; 1998 Feb; 15(1):88-93. PubMed ID: 9527304
[No Abstract] [Full Text] [Related]
8. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
[TBL] [Abstract][Full Text] [Related]
9. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
Goldstein SE; Levy Y; Shoenfeld Y
Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
[TBL] [Abstract][Full Text] [Related]
10. [Drug induced pulmonary hypertension].
Sato N; Nakanishi N
Nihon Rinsho; 2001 Jun; 59(6):1197-202. PubMed ID: 11411136
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension as a result of drug therapy.
Higenbottam T; Laude L; Emery C; Essener M
Clin Chest Med; 2004 Mar; 25(1):123-31. PubMed ID: 15062604
[TBL] [Abstract][Full Text] [Related]
12. [Anorectics and pulmonary hypertension].
Bíbová J; Hampl V
Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744
[TBL] [Abstract][Full Text] [Related]
13. Fenfluramine: riddle or Rosetta stone?
Weir EK; Obreztchikova M; Hong Z
Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944
[No Abstract] [Full Text] [Related]
14. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?
MacLean MR
Trends Pharmacol Sci; 1999 Dec; 20(12):490-5. PubMed ID: 10603491
[TBL] [Abstract][Full Text] [Related]
16. Fen-phen manufacturers, not physicians, are liable.
Allen S; Henderson J
Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016
[No Abstract] [Full Text] [Related]
17. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity.
Anchors M
Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245
[No Abstract] [Full Text] [Related]
18. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
Gross SB
Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.
den Toom ML; Grinwis G; van Suylen RJ; Boroffka SA; de Jong P; van Steenbeek FG; Szatmári V
Acta Vet Scand; 2018 Dec; 60(1):78. PubMed ID: 30518401
[TBL] [Abstract][Full Text] [Related]
20. Fenfluramine potentiates canine pulmonary vasoreactivity to endothelin-1.
Barman SA; Isales CM
Pulm Pharmacol Ther; 1998; 11(2-3):183-7. PubMed ID: 9918753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
